To identify SNF2L target proteins involved in GSH homeostasis in cancer cells, we conducted a mass spectrometry-based quantitative proteomic screening of SNF2L-deficient and parental MDA-MB-231 cells (Fig. 4A). The gene discussed is SMARCA1; the disease is cancer.